v3.22.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 56,377 $ 69,593
Prepaid expenses and other current assets 1,012 914
Total current assets 57,389 70,507
Property and equipment, net 103 117
SAFE (see Note 1) 8,000
Right-of-use assets 140 228
Deposits and other assets 17 27
Total assets 65,649 70,879
Current liabilities:    
Accounts payable 966 519
Accrued expenses 796 548
Accrued compensation expense 678 748
Accrued clinical trial expenses 462
Current operating lease liabilities 151 185
Total current liabilities 2,591 2,462
Long term operating lease liabilities 52
Total liabilities 2,591 2,514
Stockholders’ equity:    
Preferred stock, no par value, 10,000 shares authorized; none outstanding
Common stock, no par value; 300,000 shares authorized; shares issued and outstanding: 39,409 as of June 30, 2022 and December 31, 2021 347,940 347,940
Additional paid-in capital 49,415 49,389
Accumulated other comprehensive loss (424) (379)
Accumulated deficit (333,873) (328,585)
Total stockholders’ equity 63,058 68,365
Total liabilities and stockholders’ equity $ 65,649 $ 70,879

Source